North America Electrocardiograph (ECG) Market Size to register a growth of 4.9% CAGR

14-03-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report North America Electrocardiograph (ECG) Market, published by KBV research, the North America Electrocardiograph (ECG) Market Size would witness market growth of 4.9% CAGR during the forecast period (2017-2023).

The Resting ECG market held the largest share in the North America Electrocardiograph (ECG) Market by Product in 2016, and would continue to be a dominant market till 2023. The Electrocardiograph (ECG) Stress ECG market is expected to witness a CAGR of 4.5% during (2017-2023).

The US market held the largest share in the North America Electrocardiograph (ECG) Market by Country in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 4.1 % during the forecast period. The Mexico market is expected to witness a CAGR of 6.7% during (2017-2023).

The Hospitals & Clinics market held the largest share in the Canada Electrocardiograph (ECG) Market by End User in 2016, and would continue to be a dominant market till 2023. The Home Settings & Ambulatory Surgical Centers (ASCs) market is expected to witness a CAGR of 128.6% during (2017-2023).

Full Report: https://www.kbvresearch.com/north-america-electrocardiograph-ecg-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the North America Electrocardiograph (ECG) Market have been discussed in the report with the elaborated company profiles of Compumed, Bionet, Mindray Medical International Limited, General Electric (GE) (GE Healthcare), Koninklijke Philips N.V (Philips Healthcare), Schiller AG, Welch Allyn, Nihon Kohden Corporation, Medtronic, and Opto Circuits Limited.